The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 06, 2014

Filed:

Mar. 15, 2013
Applicant:

Biodesix, Inc., Boulder, CO (US);

Inventors:

Joanna Röder, Steamboat Springs, CO (US);

Heinrich Röder, Steamboat Springs, CO (US);

Julia Grigorieva, Steamboat Springs, CO (US);

Assignee:

Biodesix, Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/50 (2006.01); G06G 7/58 (2006.01); G06G 7/48 (2006.01); G06F 19/00 (2011.01);
U.S. Cl.
CPC ...
G06F 19/3437 (2013.01); G06F 19/345 (2013.01);
Abstract

A testing method for identification whether a cancer patient is a member of a group or class of cancer patients that are not likely to benefit from administration of a platinum-based chemotherapy agent, e.g., cisplatin, carboplatin or analogs thereof, either alone or in combination with other non-platinum chemotherapy agents, e.g., gemcitabine and paclitaxel. This identification can be made in advance of treatment. The method uses a mass spectrometer obtaining a mass spectrum of a blood-based sample from the patient, and a computer operating as a classifier and using a stored training set comprising class-labeled spectra from other cancer patients.


Find Patent Forward Citations

Loading…